Levocetirizine Dihydrochloride Pricing Report ​2024​: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Levocetirizine Dihydrochloride Pricing Report ​2024​: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Report Format: PDF+Excel | Report ID: SR112024A23279
Buy Now

Levocetirizine Dihydrochloride Prices June 2023

Product
Category Region Price
Levocetirizine Dihydrochloride Pharma API USA 593318 USD/MT
Levocetirizine Dihydrochloride Pharma API China 556890 USD/MT
Levocetirizine Dihydrochloride Pharma API Germany 578474 USD/MT


Exports continue to rise in the USA  and resulted in oversaturation of the market and a decline in prices. This can also be because of the hikes in the interest rates by the Federal reserve as they lower the inflation and hence influence the demand for medication in the country. The price of levocetirizine dihydrochloride in the USA reached 593318 USD/MT in June 2023.

The price trend of levocetirizine dihydrochloride was 556890 USD/MT in China during the Q2 of 2023. The manufacturing PMI for China floated below the 50, pointing to a decline in manufacturing activities. This slowdown reduced the production and demand for the pharmaceutical products, which, in turn, decreased the prices.

The manufacturing PMI points towards the shrinking German manufacturing industry which signals economic hardships arising from the COVID-19 pandemic consequences. It is evidenced by decreased new orders originating from end individuals, which also contributed to the extension of the falling trend in the prices of levocetirizine dihydrochloride. The price of levocetirizine dihydrochloride was 578474 USD/MT in June 2023 for the German market.

Levocetirizine Dihydrochloride Price Trend, Market Analysis, and News

IMARC’s newly published report, titled Levocetirizine Dihydrochloride Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data, offers an in-depth analysis of levocetirizine dihydrochloride pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot prices at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of price trends across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing levocetirizine dihydrochloride price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Levocetirizine Dihydrochloride Price Trend

Levocetirizine Dihydrochloride Market Analysis

The global levocetirizine dihydrochloride market size reached 4308 Tons in 2023. By 2032, IMARC Group expects the market to reach 9052 Tons, at a projected CAGR of 8.6% during 2023-2032.

  • The increasing prevalence of allergic conditions such as rhinitis and chronic urticaria is catalyzing the demand for effective antihistamine treatments and medications like levocetirizine dihydrochloride.
  • The heightened awareness among the masses regarding the benefits of early and sustained treatment of allergies is propelling market growth. As public knowledge about allergy management is rising, more individuals are seeking reliable and long-term solutions, thereby increasing the consumption of levocetirizine dihydrochloride.
  • Ongoing advancements in pharmaceutical formulations and the introduction of novel drug delivery systems are enhancing the market's expansion. These innovations not only improve patient compliance but also extend the availability of drugs in various forms, including oral tablets and syrups, catering to a broader patient demographic.
  • Regulatory approvals and the inclusion of levocetirizine dihydrochloride in national healthcare programs across various countries are facilitating its accessibility and affordability. Governing agencies endorsements and health insurance coverage are making the drug more accessible to the general population, thus supporting market growth.
  • The World Health Organization (WHO) shows that individuals aged over 60 is expected to double by 2050, reaching nearly 2.1 billion worldwide. As the global population continuous to age they are leading to an increased susceptibility to various allergic conditions such as rhinitis and chronic urticaria. This demographic shift results in a higher demand for effective antihistamines, like levocetirizine dihydrochloride to manage and alleviate allergy symptoms.
  • The global expansion of API manufacturing facilities, particularly in emerging markets, is significantly reduced production costs. This reduction in costs makes more affordable pricing for levocetirizine dihydrochloride. As per the IMARC Group’s report the global active pharmaceutical ingredients (API) are expected to reach US$ 357.0 Billion by 2032.
  • Advancements in drug delivery systems, such as nasal sprays, oral dissolvable films, and extended-release formulations, can enhance the convenience and efficacy of levocetirizine dihydrochloride. Moreover, developing new indications for levocetirizine dihydrochloride beyond allergic conditions, such as its potential efficacy in other inflammatory or autoimmune disorders, is facilitating the growth of the market.

Levocetirizine Dihydrochloride News

The report covers the latest developments, updates, and trends impacting the global levocetirizine dihydrochloride market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in levocetirizine dihydrochloride production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that shape the industry landscape.

Latest developments in the levocetirizine dihydrochloride industry:

  • In 2024, Supriya Life science aims to double revenue to Rs 1,000 crore by venturing into higher-margin niche segments. They are expanding their products, diversifying into contract manufacturing, and targeting regulated markets through R&D and filings for new products.

Product Description

Levocetirizine dihydrochloride is a specific antihistamine drug which is widely used in the management of some allergies like hay fever, urticaria and other similar allergic reactions. It exists in capsule, oral suspension or solution form and can be used occasionally in conjunction with other drugs to provide extra comfort. It is termed as a second-generation antihistamine this means that it is comparatively newer and has lesser effects than the first generation of antihistamines. It hardly interferes with the central nervous system hence people can carry out their activities effectively while using the drugs. Levocetirizine is an antagonist of histamine by binding competitively to the histamine receptors which are present in the body and are responsible for allergic conditions. It is available either by the counter or prescription and goes by various brand names.

Regional Coverage

The report provides a detailed analysis of the levocetirizine dihydrochloride market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the levocetirizine dihydrochloride price trend. 

Global Levocetirizine Dihydrochloride Price

The report offers a holistic view of the global levocetirizine dihydrochloride pricing trends, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level.

Europe Levocetirizine Dihydrochloride Price

The subdued purchasing activity in the market during Q2 of 2023 signaled low demand for levocetirizine dihydrochloride and applied a downward pressure on the prices.  The German economy was also under the attack of a higher fixed interest rate and inflation rate by the European Central Bank. The cost of living increased, which minimized the purchasing power of the customers, and, as a result, demand for pharmaceutical products decreased.

The pricing dynamics of levocetirizine dihydrochloride in the European region, particularly in Germany, during Q1 2024 displayed a nuanced pattern influenced by various factors like the overall trend indicated a decrease in prices during this period. Germany was in a tough market situation with no business optimism and deteriorating consumer confidence. This, in turn, caused low demand from the pharmaceutical and health sectors.

This analysis can be extended to include detailed levocetirizine dihydrochloride price information for a comprehensive list of countries.

Region Countries Covered
Europe Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries.


North America Levocetirizine Dihydrochloride Price

The massive excess supply was of levocetirizine dihydrochloride mainly because of increased exports from China to the United States. In addition, low active pharmaceutical ingredient prices were also important in reducing the overall production cost in Q2 2023, so that lower prices could be charged in the market.

The pricing dynamics of levocetirizine dihydrochloride in the North America in the first quarter of 2024, mainly in the USA market were influenced by a various aspect. These factors interacted to shape the pricing trend, with notable attention focused on the interplay between supply and demand dynamics, market sentiment, and prevailing economic conditions.

Specific data on levocetirizine dihydrochloride prices within the United States and Canada can also be provided.

Region Countries Covered
North America United States and Canada


Middle East and Africa Levocetirizine Dihydrochloride Price

The report explores the levocetirizine dihydrochloride pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on levocetirizine dihydrochloride prices for countries can also be provided.

Region Countries Covered
Middle East & Africa Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries.


Asia Pacific Levocetirizine Dihydrochloride Price

There was ample quantity of levocetirizine dihydrochloride present in the Asia Pacific market during quarter 2 of 2023. This is attributed to effective production lines or enhanced manufacturing throughput. Alike, domestic and international markets are likely to have experienced reduced demand for levocetirizine dihydrochloride due to factors such as change in consumers’ preference, market saturation, or economic challenges. This is evident from the economic fluctuations such as the devaluation of the yuan to the U. S dollar which portrays weak economy in China.

As for the first quarter of 2024, the deceased demand from the downstream sectors may have resulted from such factors as the reduced purchasing power of the population, the decreased frequency of their visits to doctors, or the changes of the existing treatment methods. Symptoms of excess capacity or desires include increased production capacities or lower demand for levocetirizine dihydrochloride than required resulting to low prices.

This analysis can be further extended to include detailed levocetirizine dihydrochloride rices for a comprehensive list of countries within the region.

Region Countries Covered
Asia Pacific China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.


Latin America Levocetirizine Dihydrochloride Price

The analysis of levocetirizine dihydrochloride prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Region Countries Covered
Latin America Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries.


Report Coverage

Key Attributes Details
Product Name Levocetirizine Dihydrochloride
Report Features Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Price Analysis, and Segment-Wise Assessment.
Currency/Units US$ (Data can also be provided in local currency) or Metric Tons
Region/Countries Covered The current coverage includes analysis at the global and regional levels only. 
 
Based on your requirements, we can also customize the report and provide specific information for the following countries: 
 
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
 
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* 
 
North America: United States and Canada

Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*

Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*

*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client.
Information Covered for Key Suppliers
  • Company Overview
  • Business Description
  • Product Portfolio
  • Recent Trends and Developments
Customization Scope The report can be customized as per the requirements of the customer
Report Price and Purchase Option

Plan A: Monthly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Month
    • Forecast for Next Month
  • Total Deliverables Per Year: 12 (One Per Month)
  • Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year

Plan B: Quarterly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Quarter
    • Forecast for Next Quarter
  • Total Deliverables Per Year: 4 (One Per Quarter)
  • Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year

Plan C: Biannually Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Half
    • Forecast for the Next Half
  • Total Deliverables Per Year: 2 (One Per 6 Months)
  • Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year
Post-Sale Analyst Support  360-degree analyst support after report delivery
Delivery Format PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) 


Key Benefits for Stakeholders:

  • IMARC’s report presents a detailed analysis of levocetirizine dihydrochloride pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
  • The study examines factors affecting levocetirizine dihydrochloride price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
  • The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
  • IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights, ensuring they remain at the forefront of the levocetirizine dihydrochloride industry.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Levocetirizine Dihydrochloride Pricing Report ​2024​: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data
Purchase options
For 2 Deliverables, Billed Annually

For 4 Deliverables, Billed Annually

For 12 Deliverables, Billed Annually


Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More